Susceptibility testing of Listeria monocytogenes a reassessment of bactericidal activity as a predictor for clinical outcome-Reference-Cited by-同舟云学术

Susceptibility testing of Listeria monocytogenes a reassessment of bactericidal activity as a predictor for clinical outcome

Published:1991-07 Issue:4 Volume:14 Page:311-317
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Appleman Maria D.,Cherubin Charles E.,Heseltine Peter N.R.,Stratton Charles W.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference43 articles.

1. Listeria monocytogenes meningitis treated with trimethoprim-sulfamethoxazole;Armstrong;Pediatr Inf Dis,1986

2. Bioactivity of imipenem as a function of medium, time and temperature;Baron;Antimicrob Agents Chemother,1984

3. Listeria;Bortolussi,1985

4. Fatal endocarditis due to Listeria monocytogenes;Carvajal;Rev Infect Dis,1988

5. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus auerus determined by the killing curve method: antibiotic comparisons and synergistic interactions;Chalkey;Antimicrob Agents Chemother,1985

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Listeriosis;Clinical Microbiology Reviews;2023-03-23

2. Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis;Canadian Journal of Infectious Diseases and Medical Microbiology;2022-10-07

3. Analysis of Genetic Diversity and Antibiotic Options for Clinical Listeria monocytogenes Infections in China;Open Forum Infectious Diseases;2021-04-09

4. Comparison of the in vitro activity of ampicillin and moxifloxacin against Listeria monocytogenes at achievable concentrations in the central nervous system;Journal of Medical Microbiology;2017-06-01

5. C-Met Inhibitors are Potential Novel Therapeutic Agents Against Listeria monocytogenes Infection Through Blocking the Bacteria Entry into Nonphagocytic Cells;Current Topics in Medicinal Chemistry;2016-11-24